CompletedNCT01160991
Olanzapine, Amisulpride, and Glucose Use in Schizophrenia
About this title
Read the official source — NCT01160991Medication studyAges 18–65Germany
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- MannheimSee all locations and recruitment
Study information
Study start dateMay 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Central Institute of Mental Health, Mannheim
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Procedure
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01160991
- Official title
Show the full official title
Effects of the Serotonin 2A Receptor on Insulin Sensitivity and Secretion: a Double-blind Controlled Comparison of Olanzapine vs. Amisulpride:
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mannheim
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Amisulpride, Olanzapine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
